Xaira

Xaira Therapeutics was founded in May 2023 and is jointly incubated by ARCH Venture Partners and Foresite Labs, one of the largest investors in biotechnology.

Xaira has a strong research team and its CEO is Dr. Marc Tessier-Lavigne, formerly Chief Scientific Officer of Genentech and former President of Rockefeller University and Stanford University.

The company's co-founder, David Baker, is an expert in the field of "AI+Protein", and has led the team to develop the AI macromodel RFdiffusion, an innovative generative AI system constructed with diffusion models, and can build AI molecules on demand. Sources say that most of Xaira Therapeutics' technology comes from David Baker and his Institute for Protein Design at the University of Washington.